Genotypic and phenotypic M. tuberculosis resistance: guiding clinicians to prescribe the correct regimens
- PMID: 29284689
- DOI: 10.1183/13993003.02292-2017
Genotypic and phenotypic M. tuberculosis resistance: guiding clinicians to prescribe the correct regimens
Conflict of interest statement
Conflict of interest: None declared.
Comment in
-
Use of Xpert MTB/RIF Ultra assays among paediatric tuberculosis experts in Europe.Eur Respir J. 2018 May 17;51(5):1800346. doi: 10.1183/13993003.00346-2018. Print 2018 May. Eur Respir J. 2018. PMID: 29773607 No abstract available.
Comment on
-
A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis.Eur Respir J. 2017 Dec 28;50(6):1701354. doi: 10.1183/13993003.01354-2017. Print 2017 Dec. Eur Respir J. 2017. PMID: 29284687 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources